The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Renal cell carcinoma with a novel germ-line mutation in isocitrate dehydrogenase 1 (IDH1) and its functional study.
Tatsuya Takayama
No relevant relationships to disclose
Mitsuhiro Kitagawa
No relevant relationships to disclose
Naohisa Takaoka
No relevant relationships to disclose
Naoyuki Sugiyama
No relevant relationships to disclose
Kaori Igarashi
No relevant relationships to disclose
Miki Miyazaki
No relevant relationships to disclose
Takayuki Sugiyama
No relevant relationships to disclose
Fumitake Kai
No relevant relationships to disclose
Tomoyoshi Soga
No relevant relationships to disclose
Seiichiro Ozono
No relevant relationships to disclose